Broadcom Crashed From $495 To $328

Broadcom is described as the author’s highest-conviction pick after its share price declined 33%, which the author attributes to an overreaction to capital-bottleneck concerns. Q3 revenue grew 86%, while AI semiconductor revenue grew 221%; guidance cited EPS targets of up to $30 for FY27–FY28. The article highlights custom silicon and software exposure to AI infrastructure spending, while noting credit risk and customer concentration.

Analysis

The key underwriting question is whether capital scarcity changes the mix of AI spend toward custom silicon and networking, or simply delays deployments. In the first case, Broadcom can gain share as customers optimize cost per workload; in the second, long design cycles and concentrated customer exposure may defer revenue while the market continues to value distant earnings less generously. Custom silicon is not insulated from hyperscaler budget cuts: customer commitment, deployment timing, and funding capacity matter more than announced project ambitions.

The claimed forward EPS outlook needs validation against the relevant reporting period, segment scope, and management guidance; it is not independently established by this article. Likewise, a sharp share-price decline alone does not establish mispricing. A potentially underappreciated downside is correlation: the same funding, power, and data-center build constraints can pressure Broadcom’s customers and competing AI infrastructure suppliers together. Conversely, inference-efficiency priorities could support custom ASIC demand even if aggregate infrastructure spending moderates.

Near term, expect the stock to remain sensitive to hyperscaler capex commentary and evidence of order or deployment slippage. Over 1–3 months, monitor Broadcom’s subsequent guidance, customer commitments, and cash conversion alongside credit conditions. Over 6–18 months, the thesis depends on custom silicon deployments scaling without a material deterioration in customer concentration or financing risk. The bullish thesis is falsified by repeated guidance cuts, delayed deployments, or weaker cash generation; it is strengthened by confirmed customer ramps despite constrained overall budgets.

Key Decisions for Investors

• Do not chase the drawdown on the article’s conviction claim alone. Verify the cited results and FY27–FY28 outlook against Broadcom filings and call transcripts, including whether figures refer to the consolidated company or a segment.
• Conditional trade: build a staged long AVGO position only if subsequent disclosures confirm customer deployment schedules and guidance. Size against the risk that concentrated customers defer orders; avoid treating distant EPS targets as a near-term valuation floor.
• For a relative-value expression, consider long AVGO against a diversified semiconductor exposure only after confirming custom-silicon demand is holding up better than broad AI infrastructure spending. Reassess if hyperscaler capex plans or Broadcom guidance weaken; no pair is warranted without that confirmation.
• Track hyperscaler capex revisions, customer concentration disclosures, cash conversion, and credit spreads over the next 1–3 months. These are more useful thesis checks than headline AI growth claims; worsening funding conditions or repeated deployment delays would invalidate the contrarian long.